GLUCAGON AMPOULE 666 1MG DIN 00015377
Status: Cancelled Post Market
Holder: ELI LILLY AND COMPANY LIMITED
Molecule: GLUCAGON (GLUCAGON HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | GLUCAGON (GLUCAGON HYDROCHLORIDE) 1 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Subcutaneous; Intramuscular; Intravenous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | H04AA01 GLUCAGON |
| Original market date | 31-Dec-1961 |
| Current status date | 27-May-2002 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly and Company — licence , not currently licensed, last inspection rating C (2025-05-12).
No Canadian shortage report is currently matched to this DIN.
Request a quote for GLUCAGON AMPOULE 666 1MG